1. Home
  2. BMEA vs CFBK Comparison

BMEA vs CFBK Comparison

Compare BMEA & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • CFBK
  • Stock Information
  • Founded
  • BMEA 2017
  • CFBK 1892
  • Country
  • BMEA United States
  • CFBK United States
  • Employees
  • BMEA N/A
  • CFBK N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • CFBK Major Banks
  • Sector
  • BMEA Health Care
  • CFBK Finance
  • Exchange
  • BMEA Nasdaq
  • CFBK Nasdaq
  • Market Cap
  • BMEA 125.4M
  • CFBK 141.5M
  • IPO Year
  • BMEA 2021
  • CFBK 1998
  • Fundamental
  • Price
  • BMEA $2.00
  • CFBK $21.89
  • Analyst Decision
  • BMEA Buy
  • CFBK
  • Analyst Count
  • BMEA 13
  • CFBK 0
  • Target Price
  • BMEA $27.92
  • CFBK N/A
  • AVG Volume (30 Days)
  • BMEA 636.9K
  • CFBK 12.5K
  • Earning Date
  • BMEA 05-01-2025
  • CFBK 05-06-2025
  • Dividend Yield
  • BMEA N/A
  • CFBK 1.28%
  • EPS Growth
  • BMEA N/A
  • CFBK N/A
  • EPS
  • BMEA N/A
  • CFBK 2.06
  • Revenue
  • BMEA N/A
  • CFBK $45,082,000.00
  • Revenue This Year
  • BMEA $191.34
  • CFBK N/A
  • Revenue Next Year
  • BMEA N/A
  • CFBK N/A
  • P/E Ratio
  • BMEA N/A
  • CFBK $10.70
  • Revenue Growth
  • BMEA N/A
  • CFBK N/A
  • 52 Week Low
  • BMEA $1.94
  • CFBK $16.92
  • 52 Week High
  • BMEA $14.43
  • CFBK $31.17
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 28.47
  • CFBK 37.42
  • Support Level
  • BMEA $2.27
  • CFBK $21.82
  • Resistance Level
  • BMEA $3.08
  • CFBK $22.30
  • Average True Range (ATR)
  • BMEA 0.23
  • CFBK 0.46
  • MACD
  • BMEA 0.00
  • CFBK 0.06
  • Stochastic Oscillator
  • BMEA 2.95
  • CFBK 39.80

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

Share on Social Networks: